<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35283119</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1026</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>828</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Science of the total environment</Title>
          <ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The assessment of environmental risk related to the occurrence of pharmaceuticals in bottom sediments of the Odra River estuary (SW Baltic Sea).</ArticleTitle>
        <Pagination>
          <StartPage>154446</StartPage>
          <MedlinePgn>154446</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2022.154446</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(22)01539-X</ELocationID>
        <Abstract>
          <AbstractText>The occurrence of 130 pharmaceutically active compounds (PhACs) in sediments collected from 70 sampling sites in the Odra River estuary (SW Baltic Sea) was investigated. The highest concentration levels of the compounds were found in the vicinity of effluent discharge from two main Szczecin wastewater treatment plants: "Pomorzany" and "Zdroje", and nearby the seaport and shipyard. The highest environmental risks (RQ &gt; 1) were observed for pseudoephedrine (RQ = 14.0), clindamycin (RQ = 7.3), nalidixic acid (RQ = 3.8), carbamazepine (RQ = 1.8), fexofenadine (RQ = 1.4), propranolol (RQ = 1.1), and thiabendazole (RQ = 1.1). RQ for each compound varied depending on the sampling sites. High environmental risk was observed in 30 sampling sites for clindamycin, 22 sampling sites for pseudoephedrine, 19 sampling sites for nalidixic acid, 4 sampling sites for carbamazepine, and 3 sampling sites for fexofenadine. The medium environmental risk (0.1 &lt; RQ &lt; 1) was observed for 16 compounds: amisulpride, amitriptyline, amlodipine, atropine, bisoprolol, chlorpromazine, lincomycin, metoprolol, mirtazapine, moclobemide, ofloxacin, oxazepam, tiapride, tolperisone, verapamil, and xylometazoline. Due to the scarcity of toxicological data related to benthic organisms, only an approximate assessment of the environmental risk of PhACs is possible. Nevertheless, the compounds with medium and high risk should be considered as pollutants of high environmental concern whose occurrence in the environment should remain under close scrutiny.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kucharski</LastName>
            <ForeName>Dawid</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Medical University of Warsaw, Department of Bioanalysis and Drugs Analysis, Banacha 1, 02-097 Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nałęcz-Jawecki</LastName>
            <ForeName>Grzegorz</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Medical University of Warsaw, Department of Environmental Health Sciences, Banacha 1, 02-097 Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drzewicz</LastName>
            <ForeName>Przemysław</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Polish Geological Institute-National Research Institute, Rakowiecka 4, 00-975 Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skowronek</LastName>
            <ForeName>Artur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Marine and Environmental Sciences, University of Szczecin, Mickiewicza 16a, 70-383 Szczecin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mianowicz</LastName>
            <ForeName>Kamila</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Interoceanmetal Joint Organization, Cyryla i Metodego 9, 71-541 Szczecin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Strzelecka</LastName>
            <ForeName>Agnieszka</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Marine and Environmental Sciences, University of Szczecin, Mickiewicza 16a, 70-383 Szczecin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Giebułtowicz</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Pharmacy, Medical University of Warsaw, Department of Bioanalysis and Drugs Analysis, Banacha 1, 02-097 Warsaw, Poland. Electronic address: joanna.giebultowicz@wum.edu.pl.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Sci Total Environ</MedlineTA>
        <NlmUniqueID>0330500</NlmUniqueID>
        <ISSNLinking>0048-9697</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014874">Water Pollutants, Chemical</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>33CM23913M</RegistryNumber>
          <NameOfSubstance UI="D002220">Carbamazepine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3B91HWA56M</RegistryNumber>
          <NameOfSubstance UI="D009268">Nalidixic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3U02EL437C</RegistryNumber>
          <NameOfSubstance UI="D002981">Clindamycin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7CUC9DDI9F</RegistryNumber>
          <NameOfSubstance UI="D054199">Pseudoephedrine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002220" MajorTopicYN="N">Carbamazepine</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002981" MajorTopicYN="N">Clindamycin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063366" MajorTopicYN="Y">Estuaries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009268" MajorTopicYN="N">Nalidixic Acid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054199" MajorTopicYN="N">Pseudoephedrine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045483" MajorTopicYN="N">Rivers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014874" MajorTopicYN="Y">Water Pollutants, Chemical</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bottom sediments</Keyword>
        <Keyword MajorTopicYN="N">Environmental risk assessment</Keyword>
        <Keyword MajorTopicYN="N">Odra River estuary</Keyword>
        <Keyword MajorTopicYN="N">Pharmaceutical pollution</Keyword>
        <Keyword MajorTopicYN="N">Pharmaceuticals in the environment</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of competing interest The authors declare no competing interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>14</Day>
          <Hour>5</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35283119</ArticleId>
        <ArticleId IdType="doi">10.1016/j.scitotenv.2022.154446</ArticleId>
        <ArticleId IdType="pii">S0048-9697(22)01539-X</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
